The estimated Net Worth of William Downie is at least $2.68 Million dollars as of 15 February 2019. William Downie owns over 12,457 units of Catalent stock worth over $2,678,103 and over the last 10 years William sold CTLT stock worth over $0.
William has made over 4 trades of the Catalent stock since 2015, according to the Form 4 filled with the SEC. Most recently William exercised 12,457 units of CTLT stock worth $307,563 on 15 February 2019.
The largest trade William's ever made was exercising 145,171 units of Catalent stock on 13 February 2015 worth over $1,554,781. On average, William trades about 14,453 units every 91 days since 2015. As of 15 February 2019 William still owns at least 44,912 units of Catalent stock.
You can see the complete history of William Downie stock trades at the bottom of the page.
William's mailing address filed with the SEC is C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET, NJ, 08873.
Over the last 10 years, insiders at Catalent have traded over $2,686,980,380 worth of Catalent stock and bought 123,000 units worth $5,376,345 . The most active insiders traders include Management Associates V L.L..., Peter Zippelius, and Frank A Damelio. On average, Catalent executives and independent directors trade stock every 17 days with the average trade being worth of $22,866,018. The most recent stock trade was executed by Ricky Hopson on 2 August 2024, trading 662 units of CTLT stock currently worth $39,429.
catalyst + talent. our name combines these ideas. from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. with over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. catalent develops. with our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. catalent delivers. as the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. catalent supplies. globally positioned to serve all your manufacturing and commercial packaging needs, we p
Catalent executives and other stock owners filed with the SEC include: